[HTML][HTML] Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO

X Kuang, Z Zhang, D Li, W Bao, J Pan, P Zhou… - Cellular & Molecular …, 2023 - Springer
Background Bladder cancer (BLCA) is a malignancy that frequently metastasizes and leads
to poor patient prognosis. It is essential to understand the molecular mechanisms underlying …

Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer

J Zhang, S Kim, L Li, CJ Kemp, C Jiang, J Lü - The Prostate, 2020 - Wiley Online Library
Background The prostate‐specific phosphatase and tensin homolog deleted on
chromosome 10 (Pten) gene‐conditional knockout (KO) mouse carcinogenesis model is …

[PDF][PDF] Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer

MD Cheng Jiang - 2020 - researchgate.net
Background: The prostate‐specific phosphatase and tensin homolog deleted on
chromosome 10 (Pten) gene‐conditional knockout (KO) mouse carcinogenesis model is …

Prävalenz und klinische Signifikanz der 16q22-Deletion beim Mammakarzinom

MM Graser - 2021 - ediss.sub.uni-hamburg.de
Das Mammakarzinom ist der häufigste maligne Tumor bei Frauen. Die Therapie besteht
üblicherweise aus einer operativen Entfernung des Tumors mit anschließender Bestrahlung …

lncRNA F11-AS1 Suppressed Cervical Cancer Biological Activities by Vitro Study

C Xu, J Zhai, Y Fu - Journal of Biomaterials and Tissue …, 2019 - ingentaconnect.com
Objection: The purpose of this work was to discuss the effects and relative mechanisms of
F11-AS1 in cervical cancer treatment by vitro study. Methods: 20 pairs of cervical carcinoma …